Compare Enzyme (MLN) vs NFPrompt (NFP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enzyme vs NFPrompt — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while NFPrompt trades at Rp33.17 (market cap Rp52,18M, Rp178,76M 24h volume). The key difference: Enzyme is far larger — about 2.6× NFPrompt's market cap, and NFPrompt's supply is capped (600,8M / 1B NFP (61%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and NFPrompt for 53 Days on average.
| MLN | NFP | |
|---|---|---|
Market Cap | Rp134,13M | Rp52,18M |
Volume (24h) | Rp104,56M | Rp178,76M |
Circulating Supply | 3,3M MLN | 600,8M / 1B NFP (61%) |
Typical Hold Time | 28 Days | 53 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
NFPrompt is currently in a bearish technical phase with a market cap of Rp52.18 million and a circulating supply of 600,800 tokens out of a maximum 1 million. The asset shows mixed signals: moving averages indicate selling pressure, while oscillators like RSI_6 at 14.95 suggest potential oversold conditions. No recent protocol updates or ecosystem news are available, indicating limited fundamental developments.
Overall outlook remains cautious due to bearish technicals and low liquidity. Key opportunities include potential rebounds from oversold RSI levels, but risks involve high volatility, thin trading volumes, and regulatory uncertainties in the crypto space. Investors should monitor support levels closely.
About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →About NFPrompt
NFPrompt is the first Prompt Artist Platform in Web3, which lets users mint their imagination into an AI-Generated NFT. Collectors and enthusiasts can buy/sell the NFT together with the prompt that was used to generate the image.
Read more on NFP →
